Nasser Khaled Altorki
#139,025
Most Influential Person Now
Nasser Khaled Altorki's AcademicInfluence.com Rankings
Nasser Khaled Altorkiphilosophy Degrees
Philosophy
#7165
World Rank
#10336
Historical Rank
Logic
#4234
World Rank
#5501
Historical Rank
Nasser Khaled Altorkibiology Degrees
Biology
#9727
World Rank
#12967
Historical Rank
Immunology
#584
World Rank
#603
Historical Rank
Download Badge
Philosophy Biology
Nasser Khaled Altorki's Degrees
- Doctorate Medicine King Saud University
Why Is Nasser Khaled Altorki Influential?
(Suggest an Edit or Addition)Nasser Khaled Altorki's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche (2005) (2975)
- Early Lung Cancer Action Project: overall design and findings from baseline screening (1999) (1993)
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance (2015) (1115)
- Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. (2010) (674)
- Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. (2001) (533)
- TOX is a critical regulator of tumour-specific T cell differentiation (2019) (526)
- The Number of Lymph Nodes Removed Predicts Survival in Esophageal Cancer: An International Study on the Impact of Extent of Surgical Resection (2008) (519)
- The lung microenvironment: an important regulator of tumour growth and metastasis (2018) (499)
- Early Lung Cancer Action Project (2001) (468)
- EMT is not required for lung metastasis but contributes to chemoresistance (2015) (417)
- Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus (2002) (401)
- MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival (2009) (390)
- Inhibition of Cyclooxygenase-2 Gene Expression by p53* (1999) (376)
- Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues (2001) (351)
- Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer (2005) (336)
- Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial. (2015) (326)
- Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial. (2016) (322)
- TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer (2010) (310)
- Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer (2011) (309)
- Predicting Systemic Disease in Patients With Esophageal Cancer After Esophagectomy: A Multinational Study on the Significance of the Number of Involved Lymph Nodes (2008) (296)
- Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. (1999) (284)
- Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial (2021) (284)
- Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. (2014) (268)
- Total Number of Resected Lymph Nodes Predicts Survival in Esophageal Cancer (2008) (258)
- Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. (2012) (252)
- Prediction of lung cancer using volatile biomarkers in breath. (2007) (238)
- Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses (2003) (230)
- Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. (2000) (228)
- Should En Bloc Esophagectomy Be the Standard of Care for Esophageal Carcinoma? (2001) (218)
- Detection of lung cancer using weighted digital analysis of breath biomarkers. (2008) (216)
- Dihydroxy Bile Acids Activate the Transcription of Cyclooxygenase-2* (1998) (211)
- Managing the small pulmonary nodule discovered by CT. (2004) (207)
- Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. (2001) (198)
- Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. (2007) (198)
- Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis (2019) (197)
- Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). (2018) (195)
- SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer (2011) (186)
- Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients1 (2004) (183)
- Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database. (2013) (181)
- High-grade dysplasia in the columnar-lined esophagus. (1991) (181)
- Interactive CardioVascular and Thoracic Surgery - 2011 Reviewers (2007) (177)
- The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome. (2015) (177)
- Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. (2009) (174)
- Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming (2008) (156)
- Tumor size predicts survival within stage IA non-small cell lung cancer. (2003) (152)
- Cardiac operations in patients with cirrhosis. (1998) (151)
- Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. (2001) (149)
- Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1 (2015) (149)
- Occult cervical nodal metastasis in esophageal cancer: preliminary results of three-field lymphadenectomy. (1997) (148)
- En bloc esophagectomy improves survival for stage III esophageal cancer. (1997) (148)
- Thoracic esophageal perforations: a decade of experience. (2003) (147)
- Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours (2000) (143)
- Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. (1998) (143)
- Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy. (2013) (139)
- Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring (2020) (138)
- Early lung cancer action project: a summary of the findings on baseline screening. (2001) (138)
- Thymic Carcinoma: A Cohort Study of Patients from the European Society of Thoracic Surgeons Database (2014) (137)
- Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. (1998) (136)
- Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer. (2010) (135)
- Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands. (2005) (134)
- Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. (2000) (133)
- Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. (1998) (133)
- Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. (2010) (127)
- Thoracic esophageal diverticula. Why is operation necessary? (1993) (121)
- Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database (2014) (114)
- CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. (2009) (113)
- Tumor‐reactive CD8+ T‐cell responses after vaccination with NY‐ESO‐1 peptide, CpG 7909 and Montanide® ISA‐51: association with survival (2009) (112)
- Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib. (2010) (111)
- Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake (2017) (110)
- Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer. (2004) (110)
- CT screening for lung cancer: prevalence and incidence of mediastinal masses. (2006) (107)
- Comparative effectiveness of robotic-assisted vs thoracoscopic lobectomy. (2014) (104)
- Lobectomy in octogenarians with non-small cell lung cancer: ramifications of increasing life expectancy and the benefits of minimally invasive surgery. (2011) (104)
- 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. (1990) (102)
- Transcriptome analysis of individual stromal cell populations identifies stroma-tumor crosstalk in mouse lung cancer model. (2015) (101)
- Lung cancer risk in white and black Americans. (2003) (100)
- Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial. (2021) (98)
- Anatomical Segmentectomy and Wedge Resections Are Associated with Comparable Outcomes for Patients with Small cT1N0 Non–Small Cell Lung Cancer (2016) (98)
- Massive hiatal hernias: the anatomic basis of repair. (1998) (97)
- The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents (1995) (95)
- CT Screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project. (2007) (92)
- Surgical resection for lung cancer in the octogenarian. (2004) (90)
- Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells. (1998) (89)
- CD8+ T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients (2002) (89)
- Tobacco smoke induces CYP1B1 in the aerodigestive tract. (2004) (87)
- Surgical management of chylothorax. (2009) (87)
- Metabolic Alterations in Lung Cancer–Associated Fibroblasts Correlated with Increased Glycolytic Metabolism of the Tumor (2013) (85)
- Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease. (2011) (84)
- PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses. (2007) (83)
- The Microenvironment of Lung Cancer and Therapeutic Implications. (2016) (83)
- Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding. (1996) (82)
- Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays. (2009) (81)
- CT-guided transthoracic needle biopsy of small solitary pulmonary nodules. (1997) (80)
- Inhibition of Cyclooxygenase‐2 (2001) (78)
- Outcomes in the management of esophageal cancer (2014) (76)
- Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs (2003) (74)
- Video-Assisted Thoracoscopic Surgery Is a Safe and Effective Alternative to Thoracotomy for Anatomical Segmentectomy in Patients With Clinical Stage I Non-Small Cell Lung Cancer. (2016) (73)
- NY-ESO-1 DNA Vaccine Induces T-Cell Responses That Are Suppressed by Regulatory T Cells (2009) (73)
- Epidemiology and molecular biology of Barrett's adenocarcinoma. (1997) (71)
- Infrequent point mutations of ras oncogenes in gastric cancers. (1990) (70)
- Intrathoracic manifestations of cervical anastomotic leaks after transthoracic esophagectomy for carcinoma. (2005) (68)
- p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state (2014) (68)
- Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma. (2007) (68)
- Multifocal Neoplasia and Nodal Metastases in T1 Esophageal Carcinoma: Implications for Endoscopic Treatment (2008) (66)
- Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503 (2017) (64)
- Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study. (1997) (64)
- Tobacco smoke stimulates the transcription of amphiregulin in human oral epithelial cells: evidence of a cyclic AMP-responsive element binding protein-dependent mechanism. (2005) (61)
- Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer. (2006) (60)
- Chemotherapy Induces the Expression of Cyclooxygenase-2 in Non–Small Cell Lung Cancer (2005) (59)
- Cancer/testis antigen CT45: Analysis of mRNA and protein expression in human cancer (2009) (58)
- Tumor size is a determinant of stage distribution in t1 non-small cell lung cancer. (2005) (57)
- Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer. (2014) (57)
- Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline. (2019) (57)
- A propensity-matched analysis of wedge resection and stereotactic body radiotherapy for early stage lung cancer. (2014) (56)
- Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6). (2006) (55)
- Ruptured descending and thoracoabdominal aortic aneurysms. (2002) (55)
- IMpower010: Primary results of a phase III global study of atezolizumab versus best supportive care after adjuvant chemotherapy in resected stage IB-IIIA non-small cell lung cancer (NSCLC). (2021) (54)
- Use of Amplatzer device for endobronchial closure of bronchopleural fistulas. (2009) (54)
- Cost containment in cardiac surgery: results with a critical pathway for coronary bypass surgery at the New York hospital-Cornell Medical Center. (1996) (53)
- Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging. (2009) (53)
- Prediction of lung cancer using volatile biomarkers in breath (2005) (53)
- The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction. (2014) (51)
- The Role of Cancer-Testis Antigens as Predictive and Prognostic Markers in Non-Small Cell Lung Cancer (2013) (50)
- 1173OMAGRIT, A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF THE RECMAGE-A3 + AS15 CANCER IMMUNOTHERAPEUTIC AS ADJUVANT THERAPY IN PATIENTS WITH RESECTED MAGE-A3-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC). (2014) (49)
- NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Regulates Levels of Bioactive Lipids in Non–Small Cell Lung Cancer (2008) (49)
- Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy. (2012) (48)
- Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma. (2011) (48)
- Characterization of cell lines established from human gastric‐esophageal adenocarcinomas: Biologic phenotype and invasion potential (1993) (47)
- Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma. (2006) (47)
- Surgical lung biopsy in adult respiratory distress syndrome: a meta-analysis. (2014) (46)
- Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors. (2011) (46)
- Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less. (2005) (46)
- A randomized, double-blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection with or without adjuvant chemotherapy in patients (pts) with stage IB-IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC): RADIANT results. (2014) (45)
- TNM stage is the most important determinant of survival in metachronous lung cancer. (2009) (45)
- Radiographic and Clinical Characterization of False Negative Results from CT-Guided Needle Biopsies of Lung Nodules (2012) (45)
- Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy. (2016) (44)
- Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma (2016) (44)
- Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. (2009) (44)
- Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma. (2011) (43)
- Differential contributions of pre- and post- EMT tumor cells in breast cancer metastasis. (2019) (43)
- Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor12 (2016) (42)
- Early lung cancer action project: annual screening using single-slice helical CT. (2001) (41)
- Robotic Thymectomy Is Feasible for Large Thymomas: A Propensity-Matched Comparison. (2017) (41)
- Surgical resection for residual N2 disease after induction chemotherapy. (2005) (40)
- Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response (2016) (40)
- Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival. (2018) (40)
- Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results database† (2018) (39)
- Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer. (2006) (39)
- En bloc esophagectomy: the first 100 patients. (1990) (38)
- Comparative analysis of diaphragmatic hernia repair outcomes using the nationwide inpatient sample database. (2012) (38)
- Lung cancer patients have the highest malignancy-associated suicide rate in USA: a population-based analysis (2018) (38)
- Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size. (2006) (38)
- The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein (2017) (37)
- Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. (2013) (37)
- Staging and the surgical management of lung cancer. (2000) (37)
- Esophageal carcinoma with airway invasion. Evolution and choices of therapy. (1994) (37)
- Full-field optical coherence tomography for the analysis of fresh unstained human lobectomy specimens (2013) (37)
- Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases. (2018) (37)
- Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid? (2007) (35)
- Characterization of Preexisting MAGE-A3-Specific CD4+ T Cells in Cancer Patients and Healthy Individuals and Their Activation by Protein Vaccination1 (2009) (35)
- Cigarette Smoke Mediates Epigenetic Repression of miR-217 During Esophageal Adenocarcinogenesis (2015) (35)
- Preoperative treatment with pazopanib (GW786034), a multikinase angiogenesis inhibitor in early-stage non-small cell lung cancer (NSCLC): A proof-of-concept phase II study (2008) (35)
- Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model. (2005) (34)
- Defining the invasive phenotype of proximal gastric cancer cells (1994) (34)
- Variability in length of stay after uncomplicated pulmonary lobectomy: is length of stay a quality metric or a patient metric?†. (2016) (33)
- CT screening for lung cancer: past and ongoing studies. (2005) (33)
- Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer. (2010) (32)
- En-bloc esophagectomy--the three-field dissection. (2005) (32)
- ECSA/DPPA2 is an Embryo-Cancer Antigen that Is Coexpressed with Cancer-Testis Antigens in Non–Small Cell Lung Cancer (2008) (31)
- Multiphoton microscopy: a potential "optical biopsy" tool for real-time evaluation of lung tumors without the need for exogenous contrast agents. (2014) (31)
- The role of CT screening for lung cancer. (2007) (31)
- Computed Tomography Screening for Lung Cancer: Mediastinal Lymph Node Resection in Stage IA Nonsmall Cell Lung Cancer Manifesting as Subsolid and Solid Nodules (2017) (31)
- The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer† (2016) (30)
- Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm. (2019) (30)
- Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer. (2017) (30)
- Imaging for esophageal tumors. (2004) (29)
- Surveillance computed tomography after complete resection for non-small cell lung cancer: results and costs. (2005) (29)
- COX-2: a target for prevention and treatment of esophageal cancer. (2004) (29)
- Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data (2015) (29)
- Incidence and Factors Associated With Hospital Readmission After Pulmonary Lobectomy. (2016) (29)
- Jungbluth AA, Chen Y‐T, Stockert E., Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ. Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues. International Journal of Cancer 2001; 92(6) 856–860. (2002) (28)
- Predictors of Survival After Treatment of Oligometastases After Esophagectomy. (2017) (28)
- Adenocarcinoma in Barrett's esophagus. (1990) (28)
- Outcome analysis of 245 CarboMedics and St. Jude valves implanted at the same institution. (1998) (27)
- Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus. (1999) (27)
- Cigarette Smoking and Risk of Lung Metastasis from Esophageal Cancer (2008) (27)
- Ratio of positron emission tomography uptake to tumor size in surgically resected non-small cell lung cancer. (2013) (27)
- Resection of a symptomatic pericardial cyst using the computer-enhanced da Vinci Surgical System. (2003) (27)
- What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer? (2017) (26)
- The effects of platelet inhibitors on blood use in cardiac surgery (2002) (26)
- Outcomes of Unresected Ground-Glass Nodules with Cytology Suspicious for Adenocarcinoma (2014) (25)
- Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis. (2018) (25)
- mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma. (1999) (25)
- Reoperative Coronary Artery Bypass Surgery Improved Preservation of Myocardial Function With Retrograde Cardioplegia (1993) (24)
- Expression of acidic fibroblast growth factor in Barrett's esophagus and associated esophageal adenocarcinoma. (1997) (24)
- Indications for esophagectomy in nonmalignant Barrett's esophagus: a 10-year experience. (1990) (24)
- Adjuvant Therapy for Node Positive Esophageal Cancer after Induction and Surgery: A Multisite Study. (2019) (23)
- Preoperative Taxane-Based Chemotherapy and Celecoxib for Carcinoma of the Esophagus and Gastroesophageal Junction: Results of a Phase 2 Trial (2011) (23)
- The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations. (2014) (23)
- Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site. (1995) (23)
- Robotic Thymectomy: Learning Curve and Associated Perioperative Outcomes. (2017) (23)
- COX-2 inhibition in upper aerodigestive tract tumors. (2004) (23)
- Adjuvant erlotinib (E) versus placebo (P) in non-small cell lung cancer (NSCLC) patients (pts) with tumors carrying EGFR-sensitizing mutations from the RADIANT trial. (2014) (23)
- Are minimum volume standards appropriate for lung and esophageal surgery? (2017) (22)
- Segmentectomy Is Equivalent to Lobectomy in Hypermetabolic Clinical Stage IA Lung Adenocarcinomas. (2019) (22)
- Preoperative Chemoradiation Therapy Versus Chemotherapy in Patients Undergoing Modified En Bloc Esophagectomy for Locally Advanced Esophageal Adenocarcinoma: Is Radiotherapy Beneficial? (2016) (22)
- In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma. (2009) (22)
- Endobronchial spread of bronchioloalveolar carcinoma. (1993) (21)
- High Grade Dysplasia: Surveillance, Mucosal Ablation, or Resection? (2003) (21)
- Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC (2015) (21)
- Pancreatic biopsy. (1983) (20)
- Incidence and implications of postoperative supraventricular tachycardia after pulmonary lobectomy. (2016) (19)
- Predictors of cervical and recurrent laryngeal lymph node metastases from esophageal cancer. (2010) (19)
- Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients. (2017) (18)
- Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice? (2019) (18)
- Video-Assisted Thoracoscopic Lobectomy Is the Preferred Approach Following Induction Chemotherapy. (2016) (18)
- Analyses of plasma cytokine/angiogenic factors (C/AFs) profile during preoperative treatment with pazopanib (GW786034) in early-stage non-small cell lung cancer (2008) (18)
- Locally advanced esophageal cancer: What becomes of 5-year survivors? (2016) (18)
- Telomerase Variant A279T Induces Telomere Dysfunction and Inhibits Non-Canonical Telomerase Activity in Esophageal Carcinomas (2014) (18)
- Sternal Reconstruction Using Customized 3D-Printed Titanium Implants. (2019) (17)
- Fischer et al. reply (2010) (17)
- CT-guided transthoracic needle biopsy following indeterminate fiberoptic bronchoscopy in solitary pulmonary nodules. (1998) (16)
- Do individual surgeon volumes affect outcomes in thoracic surgery? (2019) (16)
- Traditional techniques of esophagectomy. (2012) (16)
- Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non-small cell lung cancer. (2015) (15)
- Zenker's diverticulum: clinical features and surgical management. (1988) (15)
- Clinical predictors of early cancer-related mortality following neoadjuvant therapy and oesophagectomy. (2015) (15)
- The rationale for radical resection. (1999) (14)
- Never smokers with resected lung cancer: different demographics, similar survival† (2018) (14)
- Benzo[a]pyrene phenols are more potent inducers of CYP1A1, CYP1B1 and COX-2 than benzo[a]pyrene glucuronides in cell lines derived from the human aerodigestive tract. (2003) (14)
- Sublobar resection is comparable to lobectomy for screen-detected lung cancer. (2021) (14)
- National trends and perioperative outcomes of robotic resection of thymic tumours in the United States: a propensity matching comparison with open and video-assisted thoracoscopic approaches†. (2019) (13)
- Complete metabolic response is not uniformly predictive of complete pathologic response after induction therapy for esophageal cancer. (2013) (13)
- Current state of imaging for lung cancer staging. (2004) (12)
- Clinical Predictors of Persistent Mediastinal Nodal Disease After Induction Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer. (2017) (12)
- Predictors of Disease-free Survival and Recurrence in Patients with Resected Bronchial Carcinoid Tumors (2015) (12)
- Prevalence and outcomes of anatomic lung resection for hemoptysis: an analysis of the nationwide inpatient sample database. (2013) (12)
- Stereotactic body radiation therapy versus wedge resection for medically inoperable stage I lung cancer: tailored therapy or one size fits all? (2010) (12)
- Proliferative myositis: a rare pseudosarcoma of the chest wall. (2002) (12)
- Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. (2023) (11)
- Extended resection of sarcomas involving the mediastinum: a 15-year experience†. (2016) (11)
- Complications of Esophageal Resection (2009) (11)
- Sublobar resection for node-negative lung cancer 2-5 cm in size. (2019) (11)
- Prevalence, outcomes, and a risk-benefit analysis of diaphragmatic hernia admissions: an examination of the National Inpatient Sample database. (2011) (11)
- Three-field lymphadenectomy for esophageal cancer. (2000) (11)
- Perioperative Outcomes after Lung Resection in Obese Patients (2014) (11)
- Pitfalls and complications of colon interposition. (1997) (11)
- Computed tomography screening: the international early lung cancer action program experience. (2015) (11)
- Multicenter, randomized phase II study of neoadjuvant pembrolizumab plus chemotherapy and chemoradiotherapy in esophageal adenocarcinoma (EAC). (2021) (11)
- P2.04-92 Neoadjuvant Durvalumab With or Without Sub-Ablative Stereotactic Radiotherapy (SBRT) in Patients with Resectable NSCLC (NCT02904954) (2019) (11)
- Outcomes of lobectomy in patients with severely compromised lung function (predicted postoperative diffusing capacity of the lung for carbon monoxide % ≤ 40%). (2013) (11)
- Diagnosis and management of early lung cancer. (2002) (10)
- Carcinoid tumor nested within a bronchogenic cyst. (2008) (10)
- T1N0 oesophageal cancer: patterns of care and outcomes over 25 years† (2018) (10)
- Hernia of Morgagni: case report. (2008) (10)
- LBA9 IMpower010: Sites of relapse and subsequent therapy from a phase III study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC (2021) (10)
- Partial Upper Sternotomy for Anterosuperior Mediastinal Surgery: An Institutional Experience (2009) (9)
- Sensitivity and specificity of fine needle aspiration for the diagnosis of mediastinal lesions. (2019) (9)
- Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression (2021) (9)
- Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report (2021) (9)
- Computerized tomographic nodule heterogeneity: present and future impact on indications for sublobar resections. (2004) (9)
- Giant cavernous hemangioma of the distal esophagus treated with esophagectomy. (2007) (8)
- Limited resection as a cure for early lung cancer: time to challenge the gold standard? (2015) (8)
- Cumulative radiation dose from medical imaging procedures in patients undergoing resection for lung cancer. (2011) (8)
- Role of wedge resection in bronchial carcinoid (BC) tumors: SEER database analysis. (2019) (8)
- Adenovirus Protein E4-ORF1 Activation of PI3 Kinase Reveals Differential Regulation of Downstream Effector Pathways in Adipocytes. (2016) (8)
- Management and Outcomes of Patients on Preoperative Plavix (Clopidogrel) Undergoing General Thoracic Surgery (2012) (8)
- Bronchioloalveolar carcinoma in small pulmonary nodules: clinical relevance. (2005) (8)
- Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients (2016) (8)
- Acidic fibroblast growth factor is expressed sequentially in the progression from Barrett's esophagus to esophageal adenocarcinoma. (2001) (8)
- Sternal Resections: New Materials for Reconstruction (2015) (7)
- Cancer-testis gene expression is associated with the methylenetetrahydrofolate reductase 677 C>T polymorphism in non-small cell lung carcinoma (2013) (7)
- Primary esophageal large T-cell lymphoma mimicking esophageal carcinoma: a case report and literature review. (2008) (7)
- EARLY DETECTION AND SCREENING OF LUNG CANCER (2008) (7)
- Localized mesothelioma tumour arising synchronously with a primary contralateral lung cancer. (2013) (7)
- Gastropericardial fistula: a late complication of esophageal reconstruction. (2012) (7)
- Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline Summary. (2020) (7)
- What is the role of wedge resection for T1a lung cancer? (2018) (7)
- Early lung cancer detection and treatment strategies. (2002) (7)
- Screening for lung cancer: challenges for the thoracic surgeon. (2011) (6)
- Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology. (2019) (6)
- Screening for Lung Cancer. (2016) (6)
- Definitive therapy for isolated esophageal metastases prolongs survival. (2012) (6)
- Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non–small cell lung cancer (2022) (6)
- Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma (2022) (6)
- Cyclooxygenase-2: a target for the prevention and treatment of cancers of the upper digestive tract. (2003) (6)
- A phase III trial to compare atezolizumab (atezo) vs best supportive care (BSC) following adjuvant chemotherapy in patients (pts) with completely resected NSCLC: IMpower010. (2017) (6)
- A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease (2022) (5)
- A new technique of subcutaneous colon interposition. (2005) (5)
- Radiation-activated secretory proteins of Scgb1a1+ club cells increase the efficacy of immune checkpoint blockade in lung cancer (2021) (5)
- Proteomic analysis of lung cancer tumors. (2006) (5)
- Adjuvant Erlotinib (E) Versus Placebo (P) for Completely Resected Stage IB-IIIA EGFR-Positive (IHC/FISH) Non-Small Cell Lung Cancer (NSCLC): RADIANT Results (2014) (5)
- Endosonography for cancer of the esophagus and cardia: is it worthwhile? (1996) (5)
- Safety of lung cancer surgery during COVID-19 in a pandemic epicenter (2022) (4)
- The NeoRes trial: questioning the benefit of radiation therapy as part of neoadjuvant therapy for esophageal adenocarcinoma. (2017) (4)
- Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring (2022) (4)
- Staple line thickening after sublobar resection: reaction or recurrence? (2020) (4)
- Induction therapy for esophageal cancer. (2013) (4)
- Segmentectomy Versus Lobectomy for Stage I Lung Cancer in Patients with Good Pulmonary Function (2011) (4)
- PD-076 Phase II randomized trial of irinotecan/docetaxel oririnotecan/gemcitabine with or without celecoxib in 2nd-line treatment of non-small-cell lung cancer (2005) (4)
- Primary inflammatory fibrosarcoma of the esophagus. (1996) (4)
- National Analysis of Short-Term Outcomes After Pulmonary Resections on Cardiopulmonary Bypass. (2015) (4)
- Validation of a Circulating Tumor DNA‐Based Next‐Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing (2021) (4)
- PS01.45: Intraoperative Blood Loss is an Independent Predictor of Poor Disease Free Survival for Patients Undergoing VATS Lobectomy for Lung Cancer: Topic: Surgery (2016) (4)
- Routine molecular testing of resected early-stage lung adenocarcinoma with targeted next-generation sequencing demonstrates a high rate of actionable mutations (2016) (4)
- Predictors of Pleural Implants in Patients With Thymic Tumors. (2016) (4)
- MAGRIT phase III trial in adjuvant NSCLC: MAGE-A3 gene expression frequency on the first 2150 patients screened and demographics of first patients randomized (2009) (4)
- Three-Field Lymph Node Dissection for Cancer of the Esophagus (2002) (4)
- MINI01.07: Predictors of Conversion to Thoracotomy in VATS Lobectomy Patients: Topic: Surgery (2016) (4)
- Common and rare EGFR mutations (EGFRm) in the RADIANT trial: Final follow-up with 5 year data. (2015) (4)
- Extended Lymphadenectomy Improves Survival After Induction Chemoradiation for Esophageal Cancer (2021) (3)
- Anti-PDL1 effect in squamous non-small cell lung cancer (2020) (3)
- Low Subcutaneous Adiposity and Mortality in Esophageal Cancer (2020) (3)
- Lymph Node Dissection for Carcinoma of the Esophagus (2007) (3)
- Abstract 4721: Epithelial to mesenchymal transition is not required for breast to lung metastasis but contributes to chemoresistance (2015) (3)
- Squamous cell carcinoma of the esophagus: Therapeutic dilemma (1994) (3)
- Abstract 3247: Genome-wide cell-free DNA mutation integration for sensitive cancer detection (2018) (3)
- Reintervention and Survival After Limited Lung Resection for Lung Cancer Treatment in Australia. (2019) (3)
- PRIMARY SURGERY FOR ADENOCARCINOMA OF THE ESOPHAGUS (2008) (2)
- Evaluation of neoadjuvant “window of opportunity” trials with targeted therapy in patients with surgically resectable non-small cell lung cancer. (2010) (2)
- Treatment of cT3N1M0/IIIA non-small cell lung cancer and the risk of underuse of surgery. (2020) (2)
- Bronchioloalveolar carcinoma and ground glass opacities. (2005) (2)
- National trends and perioperative outcomes of robotic oesophagectomy following induction chemoradiation therapy: a National Cancer Database propensity-matched analysis. (2020) (2)
- Booster vaccination of non-small cell lung cancer (NSCLC) patients with MAGEA3 protein and AS02B adjuvant (2007) (2)
- PS01.55: IMpower010: Phase III Study of Atezolizumab vs BSC After Adjuvant Chemotherapy in Patients with Completely Resected NSCLC: Topic: Medical Oncology (2016) (2)
- Final follow-up (f/u) results from RADIANT: A randomized double blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection in patients (pts) with stage IB–IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC). (2015) (2)
- A simple solution for management of the postpneumonectomy empyema cavity. (2004) (2)
- P37.04 EGFR Mutations in US Hispanics with Lung Adenocarcinoma are Common and Portend a Worse Prognosis (2021) (2)
- Kaplan et al. reply (2009) (2)
- O-060PULMONARY SARCOMATOID CARCINOMA: AN ANALYSIS OF A RARE CANCER FROM THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER) DATABASE (2017) (2)
- Implementing lung cancer screening: a checklist (2014) (2)
- Commentary: Lobectomy or sublobar resection for early lung cancer: One small step for surgeons, one giant step for patients. (2019) (2)
- PS01.46: Robotic Thymectomy: Early Stage Thymoma and Non‐Tumor Benign Lesions has Comparable Perioperative Outcomes: Topic: Surgery (2016) (2)
- Extent of Resection Influences Survival in Early-Stage Lung Cancer with Occult Nodal Disease. (2022) (2)
- Two-field lymph node dissection or three-field lymph node dissection. What's in a name? (2021) (2)
- Analysis of treatment duration and safety of adjuvant erlotinib (E) versus placebo (P) after surgery in patients (pts) with non-small cell lung cancer (NSCLC): RADIANT trial. (2014) (2)
- Regulation of tumor progression and metastasis by bone marrow-derived microenvironments (2017) (2)
- 1174OPROGNOSTIC AND PREDICTIVE ROLES OF EGFR COPY NUMBER AND KRAS MUTATION STATUS FROM THE RADIANT TRIAL OF ADJUVANT ERLOTINIB (E) VERSUS PLACEBO (P). (2014) (2)
- Commentary: Surgery for ground-glass nodules: Free lunch or slippery slope? (2020) (1)
- Esophagectomy and Reconstruction (2003) (1)
- Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non-small cell lung cancer: Results from a randomized trial. (2022) (1)
- Optimal Lymph Node Dissection in Esophageal Cancer (2014) (1)
- Author response: Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake (2017) (1)
- Quality of lymphadenectomy for esophageal cancer in the United States: An analysis of the SEER database. (2011) (1)
- 1177PDEGFR DEL19/L858R ACTIVATING MUTATION (M+) SUBGROUP IN RADIANT: BASELINE CHARACTERISTICS, PROGNOSTIC ROLE, AND DISEASE-FREE SURVIVAL (DFS) BY STAGE. (2014) (1)
- Adult onset asthma. (2010) (1)
- Achalasia of the esophagus. (1994) (1)
- Commentary: Can machine learning reduce readmissions after esophagectomy? A consummation devoutly to be wished. (2020) (1)
- P3.02c-050 IMpower010: Phase III Study of Atezolizumab vs BSC after Adjuvant Chemotherapy in Patients with Completely Resected NSCLC: Topic: IT (2016) (1)
- P2.04-004 IMpower010: A Phase III Study of Atezolizumab vs Best Supportive Care Following Adjuvant Chemotherapy in Completely Resected NSCLC (2017) (1)
- Clinical Issues in the Surgical Management of Screen-Identified Lung Cancers. (2015) (1)
- Thymic carcinoma: A cohort study of prognostic factors after surgical resection from the European Society of Thoracic Surgeons database. (2013) (1)
- The lung microenvironment: an important regulator of tumour growth and metastasis (2018) (1)
- A phase II trial of preoperative paclitaxel/ carboplatin with celecoxib followed by adjuvant celecoxib for esophageal cancer: Preliminary report (2005) (1)
- PS01.42: Predictors of Incomplete Esophageal Cancer Resection: Questionable Role of Preoperative Therapy: Topic: Surgery (2016) (1)
- Molecular Testing for Early Lung Cancer. (2018) (1)
- Surgery is the Optimum Local Therapeutic Modality for Second Primary Lung Cancer. (2016) (1)
- Tumor-reactive CD8 1 T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide V (2010) (1)
- Lymph Node Metastasis of Squamous Cell Carcinoma in the Thoracic Esophagus as a Prognostic Factor (1993) (1)
- Inaugural discussions in cardiothoracic treatment and care: surgery for esophageal cancer, November 16, 2012, Boston, MA. (2013) (1)
- A Novel Platform for Proteomic Analysis of Proximal Source Pulmonary Venous Blood Identifies Potential Biomarkers for Non-Small Cell Lung Cancer (NSCLC) (2014) (1)
- Lymph Node Dissection for Carcinoma of the Cardia—Is It Worthwhile? (1993) (1)
- 429TiP IMpower010: A Phase III trial investigating atezolizumab (atezo) vs best supportive care (BSC) after adjuvant chemotherapy (chemo) in patients (pts) with completely resected NSCLC (2016) (1)
- Abstract 1820: Art1, an extracellular mono-ADP-ribosyltransferase, is upregulated in response to cellular stress and promotes lung cancer growth (2020) (1)
- OA06.07 Predictors and Consequences of Refusing Surgery for Clinical Stage I NSCLC: A National Cancer Database Analysis (2018) (1)
- Protein and DNA-Based Vaccines With the NY-ESO-1 Antigen in Cancer Patients (2005) (1)
- A05 ART1, a Mono-ADP-Ribosyltransferase, Regulates Tumor-Infiltrating CD8+ T Cells and Is Highly Expressed in EGFR Mutated Lung Cancers (2020) (1)
- Investigation of Barrett's esophagus by ultraviolet and visible fluorescence emission and excitation spectroscopy (1999) (1)
- Abstract 4498: Targeting IRE1a-XBP1 signaling in lung cancer (2017) (0)
- 1178PDCOMMON AND RARE EGFR MUTATIONS (EGFRM) IN THE RADIANT TRIAL. (2014) (0)
- Radical esophagectomy. (1992) (0)
- Integration of New Systemic Adjuvant Therapies for Non-Small Cell Lung Cancer: Role of the Surgeon. (2022) (0)
- Standard markers for detection of circulating tumor cells are variably expressed in pulmonary adenocarcinomas and are downregulated in cells undergoing mesenchymal transition (2012) (0)
- PS01.26: Prognostic Value of the New WHO Thymoma Classification: Single Institution Cross Validation Study: Topic: Pathology (2016) (0)
- Title: A Randomized, Open-Label, Multinational Phase 3 Trial Comparing Amrubicin Versus Topotecan in Patients with Extensive or Limited and Sensitive or Refractory (2007) (0)
- Reply: To PMID 19272548. (2015) (0)
- Open Radical En Bloc Esophagectomy (2015) (0)
- Abstract 3196: Genetic and pharmacologic approaches to overcome epithelial to mesenchymal mediated chemoresistance in breast cancer (2017) (0)
- Hemangiogenic response after pre-operative COX2 inhibition predicts recurrence in esophageal cancer (2007) (0)
- MAGE-3 Protein in Lung Cancer Patients Vaccine-Induced CD4+ T Cell Responses to (2013) (0)
- T1644 Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of PostOperative Disease Recurrence in Esophageal Cancer (2010) (0)
- Invited Commentary. (2017) (0)
- P-275CD44HIGH/CD24LOW LUNG CANCERS COORDINATELY OVEREXPRESS CANCER TESTIS ANTIGENS (2015) (0)
- Proximity proteome mapping reveals PD-L1-dependent pathways disrupted by anti-PD-L1 antibody specifically in EGFR-mutant lung cancer cells (2022) (0)
- Abstract 301: Microenvironmental regulation of epithelial-mesenchymal transitions in breast cancer metastasis. (2013) (0)
- Improved survival in N2 non-small cell lung cancer: better staging or better treatment; a SEER database retrospective cohort analysis (2022) (0)
- Analysis of Spontaneous Vs. Vaccine-Induced Antibody Responses Against Cancer-Testis Antigen MAGE-A3 in Cancer Patients (2011) (0)
- David Bernt Skinner (1935-2003): a thoracic surgeon and something more * * Title of presidential add (2003) (0)
- Abstract 2378: Methylmalonic acid is elevated in non-small cell lung cancer and promotes drug resistance (2022) (0)
- OA06.03 Sublobar Resection is Equivalent to Lobectomy for Screen Detected Lung Cancer (2018) (0)
- Evolution of immune escape mechanisms in the progression from preinvasive to invasive human lung adenocarcinoma (2020) (0)
- P08.04 Progress in Early Stage Lung Cancer Among Economically Disadvantaged Patients (2021) (0)
- Ten-year Survival and Recurrence Patterns after Three-field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus. (2022) (0)
- P1.16-49 Treatment of NSCLC Patients with Clinical N1 Disease: Is There an Advantage to Neoadjuvant Therapy? (2018) (0)
- F-147THE IMPORTANCE OF LYMPH NODE DISSECTION ACCOMPANYING WEDGE RESECTION FOR CLINICAL STAGE IA LUNG CANCER (2016) (0)
- Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis (2019) (0)
- Unique roles for Akt isoforms in lung cancer (2016) (0)
- Two-Field vs. Three-Field Lymphadenectomy for Esophageal Adenocarcinoma (2020) (0)
- Extended resections in the management of esophageal carcinoma. (1994) (0)
- Abstract 3214: Genome-wide analysis of stroma-tumor crosstalk pathways in lung cancer: therapeutic implications (2015) (0)
- Outcomes After a Benign Result From a CT Guided Transthoracic Fine Needle Aspiration Of a Pulmonary Nodule (2010) (0)
- Invited commentary. (2009) (0)
- An asterisk indicates reviewers who have evaluated three or more manuscripts in 2012. (2013) (0)
- Imaging modalities in general thoracic surgery (2004) (0)
- Radical En Bloc Esophagectomy for Carcinoma of the Esophagus (2005) (0)
- MA06.03 Poor Pulmonary Function Does Not Define “Medical Inoperability”: Short and Long Term Results of a Matched Lung Cancer Cohort (2019) (0)
- lPathophysiology of Gastroesophageal Reflux (1989) (0)
- Paraesophageal hernia repair (2000) (0)
- F-031NEVER-SMOKERS WITH RESECTED LUNG CANCER: DIFFERENT DEMOGRAPHICS BUT SIMILAR SURVIVAL (2017) (0)
- PKM2 mediates anti-tumor immunity and T cell dysfunction a dominant suppressor of anti-tumor immunity, reducing immunotherapeutic efficacy and ben-efittopatients;ourworkwillidentifynovelmediatorsofthisprocessforboththerapeuticpotentialandunderlyingmechanism,allowingforbothpotentialimmediateclinicalu (2021) (0)
- 965 Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway to generate TCF1+ progenitor CD8 T cells to improve efficacy of PD-1 checkpoint blockade (2022) (0)
- Abstract 2637: Impact of pre-diagnosis weight loss on outcomes in a prospective cohort of esophageal cancer patients (2016) (0)
- 52350 PKM2 mediates anti-tumor immunity and T cell dysfunction (2021) (0)
- Commentary: High-dose induction chemoradiation for lung cancer: The past is prologue. (2020) (0)
- Images in cardiothoracic surgery. A case of severe heartburn. (2009) (0)
- Volume outcome relationship in post-esophagectomy leak: A systematic review and meta-analysis. (2023) (0)
- Abstract 4944: Modeling tumor dormancy by using EMT lineage tracing under chemotherapy (2017) (0)
- PUB004 Preoperative Therapy is Not Required for Clinically Occult N2 Non-Small Cell Lung Cancer (2017) (0)
- Commentary: Where is the leak? From the anastomosis or the database? (2020) (0)
- Abstract 1713: Transferrin receptor 1 (TfR) as marker for circulating tumor cells (CTCs) identification in NSCLC (2017) (0)
- Reviewer Acknowledgements 2020 (2021) (0)
- NY-ESO-1 as a predictive marker for neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer (NSCLC). (2011) (0)
- Bone Marrow Induces STAT3 Pathway Activation in a Model of Disseminated Non-Small Cell Lung Cancer Cells (2014) (0)
- Outcomes Following Surgical Resection of Early-Stage Lung Adenocarcinomas with EGFR mutations. (2021) (0)
- Three and six month mortality best represents treatment related risk after esophagectomy (2011) (0)
- PUB006 Impact of the New WHO Classification of Thymic Tumors: Cross-Validation of the Prognostic Value in a Single Institution Cohort (2017) (0)
- Improving outcomes in patients with oesophageal cancer. (2023) (0)
- Activation by Protein Vaccination Patients and Healthy Individuals and Their T Cells in Cancer + MAGE-A3-Specific CD4 Characterization of Preexisting (2009) (0)
- Invited commentary. (2014) (0)
- Preoperative chemoradiation versus preoperative chemotherapy alone for esophageal cancer: Higher response rates but equivalent survival. (2014) (0)
- Author's response to reviews Title: Cancer-testis gene expression is associated with the methylenetetrahydrofolate reductase 677 C>T polymorphism in non-small cell lung carcinoma (2013) (0)
- Imaging for Esophageal Tumors (2005) (0)
- Abstract 603: Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway to generate TCF1+ progenitor CD8+ T cells to improve checkpoint blockade (2023) (0)
- Cox-2 Induction Therapy For Non-Small Cell Lung Cancer(Combined Modality for N_2-IIIA) (2003) (0)
- A Knock-in Mouse Model of Thymoma with the GTF2I L424H Mutation. (2022) (0)
- Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial. (2023) (0)
- Therapeutic anti-PD-L1 antibody affects ESCRT-mediated functions in cells expressing oncogenic EGFR (2021) (0)
- Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer (2023) (0)
- Cancer of the esophagus associated with esophagorespiratory tract fustula (1990) (0)
- Invited commentary. (2013) (0)
- PUB008 1,000 Video-Assisted Thoracoscopic Lobectomies (VATS): A Single Institution's Experience (2017) (0)
- F-047CLINICAL T1N0 OESOPHAGEAL CANCER: PATTERNS OF CARE AND OUTCOMES OVER 25 YEARS (2017) (0)
- Abstract 1420: Mechanisms of stroma-derived CCL7 in promoting lung cancer. (2013) (0)
- CORONARY ARTERY BYPASS IN PATIENTS WITH SEVERE LEFT VENTRICULAR DYSFUNCTION (1999) (0)
- PUB005 Robotic Thymectomy: Comparable Perioperative Outcomes for Benign Lesions and Early Stage Thymic Tumors (2017) (0)
- Abstract 5884: Targeting T regulatory cells to intercept progression from preinvasive to invasive lung adenocarcinoma using a novel KRAS-driven murine model (2023) (0)
- Signal transduction in tumor angiogenesis (2015) (0)
- P2.18-06 Trends and Outcomes of Minimally Invasive Approaches for Lung Cancer Resection After Induction Therapy in the United States (2019) (0)
- PS01.43: Clinically Occult N2 Non–Small Cell Lung Cancer: Timing of Chemotherapy does not affect the Oncologic Outcomes.: Topic: Surgery (2016) (0)
- Invited Commentary (1999) (0)
- Invited commentary. (2013) (0)
- Serological identification proteins as highly immur antigens in small cell lun (2016) (0)
- P1.12-02 Nationwide Assessment of the Role of Adjuvant Systemic Therapy in High-Risk Lung Carcinoids (2019) (0)
- Interactive CardioVascular and Thoracic Surgery – 2019 reviewers (2020) (0)
- Thank you to our reviewers (2020) (0)
- Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring (2020) (0)
- Localizing small nodules: Is it time for a randomized trial? (2017) (0)
- Invited Commentary. (2015) (0)
- ESOPHAGECTOMY FOR BARRETT'S ESOPHAGUS. REPLY (1990) (0)
- 18. NY-ESO-1 as a predictive marker for neoadjuvant chemotherapy in stage 3a non- small-cell lung cancer (NSCLC) (2012) (0)
- PS1-5 IMpower010: results from Asian patients in a phase 3 study of adjuvant atezolizumab in resected stage IB-IIIA NSCLC (2022) (0)
- Invited Commentary. (2015) (0)
- Commentary (2005) (0)
- Abstract 2073: Neutrophil serine proteases, cathepsin-G and elastase, promote metastasis through cleavage of thrombospondin-1 (2014) (0)
- The benefit of extended lymphadenectomy in esophageal cancer depends upon nodal disease burden (2011) (0)
- Targeting immunosuppressive mechanisms in KRAS mutant lung cancer (2016) (0)
- Phase I study of epigenetic priming using azacitidine prior to neoadjuvant chemotherapy in patients with resectable esophageal and gastric adenocarcinoma. (2014) (0)
- Surgical resection for multifocal (T4 or M1) non-small cell lung cancer (NSCLC): Are the T4 and M1 designations valid? (2005) (0)
- ART1, an extracellular ADP-ribosyltransferase, is over-expressed in non-small cell lung cancer and facilitates cancer cell survival by immune-mediated mechanisms (2016) (0)
- ORAL02.04: Predictors of Adverse Perioperative Outcome Following Lobectomy: A Population Based Analysis: Topic: Surgery (2016) (0)
- Author Correction: Radiation-activated secretory proteins of Scgb1a1+ club cells increase the efficacy of immune checkpoint blockade in lung cancer (2022) (0)
- Abstract B062: Differences of transcriptional profiles between long-term tolerized and memory CD4 T cells (2016) (0)
- Invited commentary. (2014) (0)
- P-252EPIRUBICIN/OXALIPLATIN/XELODA VERSUS OTHER PLATINUM BASED DOUBLETS FOR NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED OESOPHAGEAL ADENOCARCINOMA (2016) (0)
- MAGE-3 Protein in Lung Cancer Patients T Cell Responses to + Vaccine-Induced CD4 (2004) (0)
- Abstract 4972: Analysis of the reprogrammed bone marrow-derived stroma in lung cancer unravels potential targets for prognosis and therapy. (2013) (0)
- Extent of Surgery for Stage IA Non-Small-Cell Lung Cancer. Reply. (2023) (0)
- Preoperative erlotinib in clinical stage I and II non-small cell lung cancer. (2010) (0)
- Abstract 1159: A novel HGF-MET paracrine signaling pathway promotes growth and resistance to chemotherapy in lung cancer (2014) (0)
- AIDS Risk in Cardiac Surgery (1998) (0)
- Whole genome error-corrected sequencing for sensitive circulating tumor DNA cancer monitoring (2022) (0)
- Mutation status matters: RAS, p53, and targeting autophagy as a potential strategy in NSCLC (2016) (0)
- PS01.44: 1,000 Video‐Assisted Thoracoscopic Lobectomies: A Single institution’s Experience: Topic: Surgery (2016) (0)
- Abstract B172: Oncogene-mediated immune microenvironments in lung cancer provide a rationale for combination therapies (2016) (0)
- Commentary: Neoadjuvant immune checkpoint monotherapy for lung cancer: Has the train left the station? (2022) (0)
- Minimally Invasive Surgery for Lung Cancer Following Neoadjuvant Therapy in the United States. (2022) (0)
- Abstract 3472: A tumor draining lymph node CD8 T cell memory response is pivotal for a decrease in recurrence after neoadjuvant anti PD-1 therapy for NSCLC (2023) (0)
- F-094CLINICAL PREDICTORS OF EARLY MORTALITY FOLLOWING NEOADJUVANT THERAPY AND OESOPHAGECTOMY (2014) (0)
- F-081VARIABILITY IN LENGTH OF STAY AFTER UNCOMPLICATED PULMONARY LOBECTOMY: IS THERE AN OPTIMAL LENGTH OF STAY? (2015) (0)
- PUB003 Predictors of Mortality, Morbidity and Prolonged Length of Stay after Lobectomy: A Population Based Analysis (2017) (0)
- Inflammation and Lung Cancer: The Link to Angiogenesis (2015) (0)
- Abstract 68: Dissecting cellular and molecular alterations in pre-invasive to invasive lung cancer progression at single-cell resolution (2023) (0)
- Adjuvant therapy for early-stage non-small cell lung cancer: The breaking of a new dawn. (2022) (0)
- Anti-PDL 1 effect in squamous non-small cell lung cancer (2020) (0)
- Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less. Authors' reply (2006) (0)
- PUB002 Predictors of Incomplete Resection in Patients Undergoing Esophagectomy for Cancer: Induction Chemotherapy Does Not Increase R0 Resection Rate (2017) (0)
- CUL4high lung adenocarcinomas are dependent on the CUL4-p21 ubiquitin signaling for proliferation and survival. (2021) (0)
- Sub-lobar resection as new standard-of-care for cT1aN0 NSCLC? (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nasser Khaled Altorki?
Nasser Khaled Altorki is affiliated with the following schools:
